- Home
- PMEC vs GNTA Comparison
PMEC vs GNTA Comparison
Compare PMEC & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$0.87
Company Overview
Basic Information| Metric | PMEC | GNTA |
|---|---|---|
| Founded | 1984 | 2014 |
| Country | Singapore | Italy |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.4M | 34.0M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | PMEC | GNTA |
|---|---|---|
| Price | $0.69 | $0.87 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 190.1K | 54.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.60 | $0.71 |
| 52 Week High | $2.44 | $10.00 |
Technical Indicators
Market Signals| Indicator | PMEC | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 39.87 | 38.57 |
| Support Level | $0.60 | $0.71 |
| Resistance Level | $1.11 | $1.70 |
| Average True Range (ATR) | 0.10 | 0.08 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 14.62 | 12.54 |
Price Performance
Historical Comparison PMEC
GNTA
About PMEC Primech Holdings Ltd.
Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.